6802-78-4

Basic information

• Product Name: 7,7-Dibromo-bicyclo[4.1.0]hept-3-ene
• Synonyms: 7,7-Dibromo-bicyclo[4.1.0]hept-3-ene
• CAS NO: 6802-78-4
• Molecular Formula: C₇H₈Br₂
• Molecular Weight: 251.96
• Mol File: 6802-78-4.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 228.8 °C at 760 mmHg
• Flash Point: 98.3 °C
• Appearance: /
• Density: 2.005 g/cm³
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 7,7-Dibromo-bicyclo[4.1.0]hept-3-ene(CAS DataBase Reference)
• NIST Chemistry Reference: 7,7-Dibromo-bicyclo[4.1.0]hept-3-ene(6802-78-4)
• EPA Substance Registry System: 7,7-Dibromo-bicyclo[4.1.0]hept-3-ene(6802-78-4)

Safety Data

• Hazardous Substances Data: 6802-78-4(Hazardous Substances Data)

Usage

General Description

7,7-Dibromo-bicyclo[4.1.0]hept-3-ene, also known as a brominated bicyclic compound, is a chemical compound with the molecular formula C7H8Br2. It is a colorless liquid with a strong, pungent odor and is insoluble in water. 7,7-Dibromo-bicyclo[4.1.0]hept-3-ene is often used as a building block in the synthesis of various organic compounds due to its versatility in chemical reactions. It is also used in pharmaceuticals, agrochemicals, and materials science. Additionally, 7,7-Dibromo-bicyclo[4.1.0]hept-3-ene has been studied for its potential applications in organic synthesis and as a starting material for the production of specialty chemicals. However, it is important to handle this compound with care, as it can be hazardous to human health and the environment.

Upstream product

• 75-25-2 Bromoform 
• 1165952-92-0 cyclohexa-1,4-diene 
• 865-47-4 potassium tert-butylate 
• 109-66-0 pentane 
• 75-65-0 tert-butyl alcohol 

Downstream Products

• 33816-51-2 5-bromo-2-methoxycyclohepta-2,4,6-trien-1-one 
• 658698-46-5 cis-4,4-dibromo-8-(toluene-4-sulfonyl)-8-azatricyclo[5.1.0.0^3,5]octane 

Relevant articles and documents

TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS

Disclosed are a series of compounds or their tautomers having a general structure represented by Formula (la), (lb), (Ila), (lIb), or (lIc) and pharmaceutically acceptable salts thereof. The present disclosure also relates to pharmaceutical compositions comprising said compounds or tautomers. The present disclosure further relates to a method of treating a disease or condition associated with iron dysregulation or dysfunctional iron homeostasis comprising administering to a subject in need thereof a therapeutically effective amount of Formula (la), (lb), (Ila), (lIb), or (lIc) compounds or tautomers.

Abnormal Nucleophilic Substitution on Methoxytropone Derivatives: Steric Strategy to Synthesize 5-Substituted Azulenes

Azulene is a non-alternant non-benzenoid aromatic system, and in turn, it possesses unusual photophysical properties. Azulene-based conjugated systems have received increasing interest in recent years as optoelectronic materials. Despite the routes availa

Tropolone-terminated oligomeric fluorophores with responsive properties to external environment

Tropolone-terminated oligomeric fluorophores (Tp20P, Tp20PV, and Tp20PE) were prepared by palladium-catalyzed coupling reactions. A phenylene-type Tp20P showed an emission maximum in the blue fluorescent region and the fluorescence quantum yield was relat